Status:
RECRUITING
Cardiovascular and Metabolic Sciences Biorepository
Lead Sponsor:
The Cleveland Clinic
Conditions:
Cardiovascular Diseases
Metabolic Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the Cardiovascular and Metabolic Sciences Biorepository is to collect and store information and biospecimens (blood, urine, stool, and heart tissue) from patients with and without cardi...
Detailed Description
Heart disease is the leading cause of death in the United States and other vascular diseases, like stroke, and metabolic diseases, like diabetes, are consistently in the top ten causes of death (CDC, ...
Eligibility Criteria
Inclusion
- Willing and able to sign the informed consent document
Exclusion
- Chronic anemia (hemoglobin consistently \<9 g/L)
Key Trial Info
Start Date :
September 18 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2050
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06560424
Start Date
September 18 2024
End Date
December 31 2050
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Main Campus
Cleveland, Ohio, United States, 44195